— Know what they know.
Not Investment Advice

ANAB NASDAQ

AnaptysBio, Inc.
1W: -2.9% 1M: +12.8% 3M: +11.5% YTD: +34.4% 1Y: +186.3% 3Y: +224.3% 5Y: +131.5%
$59.71
-0.70 (-1.16%)
 
Weekly Expected Move ±13.3%
$46 $55 $63 $72 $80
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 57 · $2.6B mcap · 40M float · 2.05% daily turnover · Short 48% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
44.2 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -12.4%
Cost Advantage
54
Intangibles
51
Switching Cost
35
Network Effect
57
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ANAB shows a Weak competitive edge (44.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -12.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$75
Low
$80
Avg Target
$90
High
Based on 3 analysts since May 12, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 16Hold: 6Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$73.38
Analysts8
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-15 Leerink Partners $85 $90 +5 +43.7% $62.65
2026-05-13 UBS $60 $76 +16 +15.9% $65.58
2026-05-13 Barclays $55 $75 +20 +14.4% $65.58
2026-04-28 Leerink Partners $45 $85 +40 +27.6% $66.59
2026-04-21 UBS $70 $60 -10 +10.6% $54.23
2026-03-06 Truist Financial John Lee $36 $50 +14 -11.2% $56.29
2026-03-05 Stifel Nicolaus Alex Thompson $56 $85 +29 +48.2% $57.36
2026-03-04 H.C. Wainwright Emily Bodnar $59 $66 +7 +13.7% $58.03
2026-01-07 UBS Michael Yee Initiated $70 +59.4% $43.91
2025-12-18 Guggenheim $54 $140 +86 +202.8% $46.23
2025-12-17 Barclays Etzer Darout $70 $55 -15 +22.1% $45.03
2025-12-11 Stifel Nicolaus $80 $56 -24 +24.6% $44.95
2025-11-11 Barclays $78 $70 -8 +106.0% $33.98
2025-11-10 Wedbush David Nierengarten $70 $50 -20 +50.3% $33.26
2025-11-10 Truist Financial Joon Lee $30 $36 +6 +5.0% $34.28
2025-10-29 Stifel Nicolaus Initiated $80 +121.2% $36.16
2025-10-15 Wedbush David Nierengarten Initiated $70 +119.8% $31.85
2025-10-13 Barclays Initiated $78 +148.6% $31.37
2025-09-30 H.C. Wainwright $19 $59 +40 +153.5% $23.27
2025-05-06 Guggenheim Yatin Suneja $52 $54 +2 +168.4% $20.12
2025-03-03 Guggenheim $90 $52 -38 +255.2% $14.64
2025-02-03 Wolfe Research Andy Chen Initiated $25 +50.1% $16.66
2024-12-11 H.C. Wainwright Emily Bodnar $52 $19 -33 +22.5% $15.51
2024-11-06 H.C. Wainwright Emily Bodnar Initiated $52 +168.3% $19.38
2024-11-06 Leerink Partners David Risinger $47 $45 -2 +132.2% $19.38
2024-10-21 Guggenheim Yatin Suneja Initiated $90 +157.3% $34.98
2024-10-15 Piper Sandler Yasmeen Rahimi Initiated $80 +130.3% $34.74
2024-10-03 New Street David Risinger Initiated $35 -0.6% $35.22
2024-08-15 Truist Financial Joon Lee Initiated $30 -13.4% $34.65
2024-04-16 Leerink Partners David Risinger Initiated $47 +121.0% $21.27
2022-11-18 J.P. Morgan Initiated $32 +9.7% $29.16

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ANAB receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-03-03 C D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

50 Grade D
Profitability
20
Balance Sheet
61
Earnings Quality
53
Growth
88
Value
32
Momentum
80
Safety
50
Cash Flow
42
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ANAB scores highest in Growth (88/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.07
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-4.51
Unlikely Manipulator
Ohlson O-Score
-5.06
Bankruptcy prob: 0.6%
Low Risk
Credit Rating
BBB
Score: 56.9/100
Trend: Improving
Earnings Quality
OCF/NI: -0.17x
Accruals: -7.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ANAB scores 2.07, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ANAB scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ANAB's score of -4.51 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ANAB's implied 0.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ANAB receives an estimated rating of BBB (score: 56.9/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-63.95x
PEG
0.18x
P/S
11.08x
P/B
134.40x
P/FCF
360.90x
P/OCF
355.34x
EV/EBITDA
24.26x
EV/Revenue
5.57x
EV/EBIT
25.41x
EV/FCF
293.42x
Earnings Yield
-1.68%
FCF Yield
0.28%
Shareholder Yield
4.03%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ANAB currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.006
NI / EBT
×
Interest Burden
-0.523
EBT / EBIT
×
EBIT Margin
0.219
EBIT / Rev
×
Asset Turnover
0.548
Rev / Assets
×
Equity Multiplier
7.848
Assets / Equity
=
ROE
-49.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ANAB's ROE of -49.6% is driven by financial leverage (equity multiplier: 7.85x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$59.71
Median 1Y
$41.98
5th Pctile
$11.02
95th Pctile
$160.87
Ann. Volatility
82.5%
Analyst Target
$73.38
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Daniel Faga
President and Chief Executive Officer and Director
$685,448 $6,889,127 $13,630,292
Paul Lizzul Medical
edical Officer
$529,859 $2,128,976 $4,583,508
Dennis Mulroy Financial
ancial Officer
$495,213 $1,196,600 $3,238,907

CEO Pay Ratio

28:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $13,630,292
Avg Employee Cost (SGA/emp): $487,856
Employees: 104

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
104
-23.5% YoY
Revenue / Employee
$2,255,798
Rev: $234,603,000
Profit / Employee
$-127,231
NI: $-13,232,000
SGA / Employee
$487,856
Avg labor cost proxy
R&D / Employee
$1,307,404
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -2.2% 2.1% -15.3% -20.2% -28.7% -35.8% -41.6% -44.2% -46.6% -47.8% -93.4% -93.3% -97.2% -94.6% -1.8% -1.8% -1.7% -1.1% -24.5% -49.6% -49.57%
ROA -2.0% 2.0% -10.9% -14.3% -20.4% -25.5% -20.5% -21.8% -23.0% -23.6% -30.8% -30.7% -32.0% -31.2% -31.0% -30.0% -28.3% -18.1% -3.1% -6.3% -6.32%
ROIC -2.3% 2.2% 26.3% 32.5% 45.1% 55.7% 57.0% 63.2% 69.3% 73.3% 45.6% 45.0% 45.0% 40.9% -1.7% -1.4% -1.2% -41.2% -14.5% -12.4% -12.38%
ROCE -2.2% 2.1% -9.2% -11.3% -15.5% -18.8% -18.4% -19.9% -21.4% -22.3% -34.5% -33.9% -34.0% -30.3% -21.7% -18.0% -14.2% -1.6% 19.7% 15.6% 15.63%
Gross Margin 15.7% -6.4% -25.5% -22.2% -16.1% -16.1% -2.4% -24.4% -8.5% -8.3% -2.7% -4.2% -2.8% -40.6% 1.2% -48.3% -69.9% 58.8% 2.0% 97.6% 97.61%
Operating Margin -1.8% -32.4% -30.8% -32.7% -22.9% -22.9% -3.8% -32.3% -11.6% -11.4% -4.7% -5.9% -3.7% -75.8% -22.4% -99.2% -1.2% 45.5% 61.8% -1.4% -1.36%
Net Margin -1.4% -31.9% -32.2% -37.4% -26.8% -25.9% -3.9% -32.2% -11.5% -11.2% -4.7% -6.1% -4.3% -1.1% -50.5% -1.4% -1.7% 19.8% 45.8% -2.1% -2.07%
EBITDA Margin 1.6% -28.7% -31.8% -31.8% -21.5% -20.7% -3.2% -28.6% -10.1% -9.7% -3.8% -5.2% -3.2% -56.1% -8.8% -74.2% -82.6% 50.1% 62.4% -1.3% -1.33%
FCF Margin 5.3% 12.5% -74.8% -84.8% -3.2% -19.7% -7.2% -7.3% -6.1% -6.5% -7.1% -5.8% -4.3% -1.8% -1.5% -97.6% -1.0% -85.8% 8.4% 1.9% 1.90%
OCF Margin 6.9% 13.9% -72.7% -82.7% -3.2% -19.6% -7.2% -7.2% -6.1% -6.5% -7.0% -5.8% -4.2% -1.8% -1.5% -97.2% -1.0% -85.5% 8.4% 1.9% 1.93%
ROE 3Y Avg snapshot only -1.52%
ROE 5Y Avg snapshot only -1.06%
ROA 3Y Avg snapshot only -24.17%
ROIC Economic snapshot only 69.05%
Cash ROA snapshot only 1.23%
NOPAT Margin snapshot only 13.87%
Pretax Margin snapshot only -11.46%
R&D / Revenue snapshot only 55.36%
SGA / Revenue snapshot only 27.03%
SBC / Revenue snapshot only 17.69%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -81.52 88.71 -16.55 -9.03 -5.30 -5.35 -6.85 -4.45 -3.76 -3.23 -3.48 -3.70 -4.03 -5.84 -2.78 -4.05 -4.82 -10.50 -114.84 -59.40 -63.954
P/S Ratio 7.01 6.09 15.15 12.96 23.77 160.72 85.69 56.89 41.87 31.87 33.19 26.29 22.50 16.93 4.42 5.09 5.19 5.24 6.48 6.85 11.080
P/B Ratio 1.79 1.88 2.68 1.92 1.61 2.02 3.36 2.32 2.07 1.82 6.46 6.85 7.78 10.99 5.69 8.04 9.02 12.54 40.84 42.76 134.396
P/FCF 132.19 48.64 -20.23 -15.29 -7.36 -8.16 -11.92 -7.84 -6.86 -4.87 -4.68 -4.50 -5.28 -9.36 -2.97 -5.22 -4.99 -6.11 77.49 360.90 360.899
P/OCF 102.16 43.87 77.14 355.34 355.338
EV/EBITDA -42.86 34.26 -7.71 -2.31 -0.48 -1.68 -4.37 -1.64 -0.98 -0.43 -1.39 -1.66 -2.25 -4.81 -4.17 -7.25 -10.46 -190.95 18.31 24.26 24.256
EV/Revenue 3.13 2.87 6.80 3.00 1.88 43.32 44.69 17.44 9.27 3.67 11.45 10.04 10.25 10.40 4.24 4.95 5.06 5.15 5.21 5.57 5.567
EV/EBIT -36.38 41.82 -7.43 -2.23 -0.47 -1.65 -4.27 -1.61 -0.96 -0.42 -1.37 -1.64 -2.22 -4.74 -4.07 -7.03 -10.05 -124.87 19.00 25.41 25.413
EV/FCF 58.99 22.93 -9.09 -3.53 -0.58 -2.20 -6.22 -2.40 -1.52 -0.56 -1.61 -1.72 -2.41 -5.75 -2.85 -5.07 -4.87 -6.00 62.31 293.42 293.417
Earnings Yield -1.2% 1.1% -6.0% -11.1% -18.9% -18.7% -14.6% -22.5% -26.6% -31.0% -28.7% -27.1% -24.8% -17.1% -36.0% -24.7% -20.7% -9.5% -0.9% -1.7% -1.68%
FCF Yield 0.8% 2.1% -4.9% -6.5% -13.6% -12.3% -8.4% -12.8% -14.6% -20.5% -21.4% -22.2% -18.9% -10.7% -33.7% -19.2% -20.0% -16.4% 1.3% 0.3% 0.28%
PEG Ratio snapshot only 0.177
Price/Tangible Book snapshot only 42.763
EV/OCF snapshot only 288.896
EV/Gross Profit snapshot only 4.782
Acquirers Multiple snapshot only 31.709
Shareholder Yield snapshot only 4.03%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 20.01 20.01 34.40 34.40 34.40 34.40 17.16 17.16 17.16 17.16 10.87 10.87 10.87 10.87 9.51 9.51 9.51 9.51 9.07 9.07 9.068
Quick Ratio 20.01 20.01 34.40 34.40 34.40 34.40 17.16 17.16 17.16 17.16 10.87 10.87 10.87 10.87 9.51 9.51 9.51 9.51 9.07 9.07 9.068
Debt/Equity 0.00 0.00 0.06 0.06 0.06 0.06 0.07 0.07 0.07 0.07 0.20 0.20 0.20 0.20 5.21 5.21 5.21 5.21 0.38 0.38 0.379
Net Debt/Equity -0.99 -0.99 -1.48 -1.48 -1.48 -1.48 -1.61 -1.61 -1.61 -1.61 -4.23 -4.23 -4.23 -4.23 -0.22 -0.22 -0.22 -0.22 -8.00 -8.00 -7.996
Debt/Assets 0.00 0.00 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.76 0.76 0.76 0.76 0.04 0.04 0.039
Debt/EBITDA -0.05 0.03 -0.38 -0.31 -0.22 -0.18 -0.18 -0.17 -0.16 -0.15 -0.13 -0.13 -0.13 -0.14 -3.98 -4.84 -6.19 -80.85 0.21 0.26 0.265
Net Debt/EBITDA 53.19 -38.42 9.46 7.70 5.54 4.55 4.01 3.71 3.44 3.29 2.64 2.69 2.68 3.02 0.17 0.21 0.27 3.48 -4.46 -5.58 -5.579
Interest Coverage -14.63 -9.07 -7.00 -5.10 -5.64 -6.55 -7.51 -7.91 -7.02 -5.29 -3.34 -1.90 -1.27 -0.88 -0.09 0.81 0.62 0.616
Equity Multiplier 1.05 1.05 1.80 1.80 1.80 1.80 2.33 2.33 2.33 2.33 5.13 5.13 5.13 5.13 6.83 6.83 6.83 6.83 9.79 9.79 9.793
Cash Ratio snapshot only 8.068
Debt Service Coverage snapshot only 0.645
Cash to Debt snapshot only 22.083
FCF to Debt snapshot only 0.312
Defensive Interval snapshot only 548.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.24 0.29 0.12 0.10 0.05 0.01 0.02 0.02 0.02 0.02 0.03 0.04 0.06 0.11 0.19 0.24 0.26 0.36 0.55 0.55 0.548
Inventory Turnover
Receivables Turnover 144.24 120.77 54.99 10.25 8.96 9.32 11.27 13.04 4.15 5.55 7.37 13.83 3.83 4.70 5.17 7.12 6.29 6.23 6.229
Payables Turnover 8.86 9.12 33.06 32.50 31.00 30.95 39.25 44.75 50.09 53.98 35.36 35.92 38.34 41.37 37.66 38.62 37.66 35.17 0.62 -9.69
DSO 0 0 3 3 7 36 41 39 32 28 88 66 50 26 95 78 71 51 58 59 58.6 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
DPO 41 40 11 11 12 12 9 8 7 7 10 10 10 9 10 9 10 10 593
Cash Conversion Cycle -41 -40 -9 -8 -5 24 31 31 25 21 78 56 40 18 86 68 61 41 -535
Fixed Asset Turnover snapshot only 16.732
Cash Velocity snapshot only 0.746
Capital Intensity snapshot only 1.568
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 4.6% 5.8% -15.8% -25.8% -76.2% -96.3% -83.7% -79.8% -46.3% 2.3% 66.8% 1.1% 1.4% 2.8% 4.3% 3.9% 3.0% 2.0% 1.6% 1.1% 1.08%
Net Income 89.3% 1.1% -1.9% -1.5% -11.4% -17.1% -1.2% -80.2% -33.3% -9.6% -27.1% -19.4% -18.1% -12.1% 11.2% 13.9% 22.1% 48.9% 90.9% 81.0% 80.95%
EPS 89.3% 1.1% -1.9% -1.5% -11.0% -16.6% -1.2% -78.6% -41.2% -16.8% -36.0% -24.6% -15.0% -3.0% 22.5% 24.7% 26.0% 49.1% 91.1% 79.7% 79.65%
FCF 1.1% 1.2% -2.2% -94.5% -15.5% -6.8% -56.4% -73.1% -1.6% -10.7% -64.4% -72.8% -64.4% -5.7% -11.6% 18.6% 1.4% -40.6% 1.1% 1.0% 1.04%
EBITDA 90.8% 1.1% -1.9% -1.3% -11.9% -12.3% -89.0% -66.1% -28.9% -10.5% -34.1% -22.0% -13.5% 3.5% 34.3% 45.0% 57.1% 96.3% 1.7% 1.7% 1.70%
Op. Income 88.9% 1.1% -1.4% -1.2% -8.9% -16.7% -1.0% -82.1% -43.8% -23.2% -42.8% -26.9% -15.9% 0.6% 30.1% 38.2% 47.0% 80.5% 1.4% 1.4% 1.41%
OCF Growth snapshot only 1.04%
Asset Growth snapshot only -24.69%
Equity Growth snapshot only -47.49%
Debt Growth snapshot only -96.18%
Shares Change snapshot only -6.37%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 2.2% 1.5% 1.3% 1.2% 34.0% -3.5% 8.7% -22.5% -10.4% -6.0% -38.8% -31.4% -33.0% -22.4% 13.1% 28.4% 72.3% 2.4% 1.8% 1.8% 1.79%
Revenue 5Y 28.0% -8.5% 0.6% 1.3% 33.9% 13.3% 28.0% 35.6% 25.0% 62.8% 62.7% 37.2% 46.9% 56.6% 25.6% 26.7% 26.67%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 8.1% 8.1% 8.1% 8.1% 8.1% 8.1% 11.9% 11.9% 11.9% 11.9% 2.8% 2.8% 2.8% 2.8% -9.0% -9.0% -9.0% -9.0% -15.8% -15.8% -15.80%
Assets 5Y 59.6% 59.6% 59.6% 13.1% 13.1% 13.1% 13.1% -2.3% -2.3% -2.3% -2.3% 2.1% 2.1% 2.1% 2.1% -2.6% -2.6% -2.64%
Equity 3Y 8.9% 8.9% -9.8% -9.8% -9.8% -9.8% -13.5% -13.5% -13.5% -13.5% -39.4% -39.4% -39.4% -39.4% -41.6% -41.6% -41.6% -41.6% -47.8% -47.8% -47.83%
Book Value 3Y 4.1% 4.3% -10.7% -10.6% -11.1% -11.2% -14.8% -14.2% -12.8% -12.7% -38.4% -39.0% -39.4% -40.5% -43.6% -43.6% -42.0% -42.1% -49.5% -48.3% -48.28%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.73 0.67 0.73 0.73 0.25 0.12 0.10 0.07 0.03 0.00 0.00 0.00 0.01 0.01 0.27 0.29 0.46 0.55 0.35 0.41 0.414
Earnings Stability 0.01 0.03 0.01 0.35 0.24 0.14 0.28 0.44 0.33 0.24 0.43 0.56 0.49 0.37 0.52 0.63 0.53 0.24 0.05 0.03 0.034
Margin Stability 0.14 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.14 0.00 0.11 0.04 0.24 0.01 0.14 0.09 0.28 0.00 0.00 0.00 0.000
Rev. Growth Consistency 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.20 0.50 0.50 0.50 0.20 0.50 0.50 0.87 0.50 0.89 0.92 0.93 0.95 0.96 0.94 0.91 0.80 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.16 0.21 -0.02 -0.07 -0.19 -0.30 -0.38 -0.38 -0.39 -0.39 -1.53 -1.49 -1.50 -1.41 -0.88 -0.80 -0.63 0.03 1.60 1.20 1.199
Gross Margin Trend 5.70 10.84 5.18 0.92 -0.88 -17.93 -7.32 -7.97 -6.40 2.49 -2.61 -0.20 1.59 11.64 6.38 6.16 5.40 4.53 4.74 3.84 3.841
FCF Margin Trend 5.07 8.70 3.74 0.82 -1.22 -17.87 -6.72 -6.68 -4.52 3.24 -3.12 -1.79 0.41 11.31 5.65 5.58 4.15 3.32 4.37 3.43 3.428
Sustainable Growth Rate 2.1%
Internal Growth Rate 2.0%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -0.80 2.02 0.79 0.58 0.72 0.65 0.57 0.56 0.54 0.66 0.74 0.82 0.76 0.62 0.93 0.77 0.96 1.71 -1.49 -0.17 -0.167
FCF/OCF 0.77 0.90 1.03 1.03 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.98 0.985
FCF/Net Income snapshot only -0.165
OCF/EBITDA snapshot only 0.084
CapEx/Revenue 1.6% 1.4% 2.2% 2.1% 1.3% 4.4% 3.5% 4.5% 4.6% 4.7% 4.7% 2.9% 1.6% 0.7% 0.4% 0.3% 0.3% 0.2% 0.0% 0.0% 0.03%
CapEx/Depreciation snapshot only 0.028
Accruals Ratio -0.04 -0.02 -0.02 -0.06 -0.06 -0.09 -0.09 -0.10 -0.10 -0.08 -0.08 -0.06 -0.08 -0.12 -0.02 -0.07 -0.01 0.13 -0.08 -0.07 -0.074
Sloan Accruals snapshot only -0.182
Cash Flow Adequacy snapshot only 64.899
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 6.2% 9.2% 10.5% 8.8% 2.1% 0.0% 0.0% 0.1% 0.9% 8.8% 7.4% 4.5% 4.0% 4.03%
Net Buyback Yield -0.1% -0.1% -0.1% -0.8% -1.0% -1.2% -1.3% 4.8% 7.7% 9.3% 8.3% 1.7% -0.3% -10.4% -24.9% -16.8% -7.0% 7.1% 3.6% 2.3% 2.28%
Total Shareholder Return -0.1% -0.1% -0.1% -0.8% -1.0% -1.2% -1.3% 4.8% 7.7% 9.3% 8.3% 1.7% -0.3% -10.4% -24.9% -16.8% -7.0% 7.1% 3.6% 2.3% 2.28%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.006
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.07 1.11 1.14 1.20 1.18 1.15 1.13 1.14 1.16 1.21 1.32 1.53 1.78 2.14 12.10 -0.20 -0.52 -0.523
EBIT Margin -0.09 0.07 -0.91 -1.34 -4.04 -26.28 -10.46 -10.86 -9.66 -8.72 -8.34 -6.13 -4.63 -2.20 -1.04 -0.70 -0.50 -0.04 0.27 0.22 0.219
Asset Turnover 0.24 0.29 0.12 0.10 0.05 0.01 0.02 0.02 0.02 0.02 0.03 0.04 0.06 0.11 0.19 0.24 0.26 0.36 0.55 0.55 0.548
Equity Multiplier 1.06 1.06 1.41 1.41 1.41 1.41 2.03 2.03 2.03 2.03 3.03 3.03 3.03 3.03 5.89 5.89 5.89 5.89 7.85 7.85 7.848
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.32 $0.31 $-2.10 $-2.74 $-3.83 $-4.77 $-4.53 $-4.89 $-5.41 $-5.57 $-6.15 $-6.09 $-6.22 $-5.73 $-4.77 $-4.59 $-4.60 $-2.92 $-0.42 $-0.93 $-0.93
Book Value/Share $14.48 $14.46 $12.95 $12.86 $12.64 $12.60 $9.21 $9.38 $9.84 $9.87 $3.31 $3.29 $3.22 $3.05 $2.33 $2.31 $2.46 $2.44 $1.19 $1.30 $0.44
Tangible Book/Share $14.48 $14.46 $12.95 $12.86 $12.64 $12.60 $9.21 $9.38 $9.84 $9.87 $3.31 $3.29 $3.22 $3.05 $2.33 $2.31 $2.46 $2.44 $1.19 $1.30 $1.30
Revenue/Share $3.70 $4.45 $2.29 $1.91 $0.85 $0.16 $0.36 $0.38 $0.49 $0.56 $0.65 $0.86 $1.11 $1.98 $3.00 $3.65 $4.28 $5.84 $7.49 $8.10 $8.10
FCF/Share $0.20 $0.56 $-1.72 $-1.62 $-2.76 $-3.13 $-2.60 $-2.78 $-2.97 $-3.69 $-4.57 $-5.01 $-4.75 $-3.58 $-4.46 $-3.56 $-4.45 $-5.01 $0.63 $0.15 $0.15
OCF/Share $0.25 $0.62 $-1.67 $-1.58 $-2.75 $-3.12 $-2.59 $-2.76 $-2.94 $-3.66 $-4.54 $-4.98 $-4.73 $-3.57 $-4.44 $-3.55 $-4.43 $-5.00 $0.63 $0.16 $0.16
Cash/Share $14.37 $14.35 $19.91 $19.78 $19.43 $19.37 $15.51 $15.79 $16.57 $16.62 $14.70 $14.59 $14.29 $13.53 $12.66 $12.58 $13.38 $13.28 $9.94 $10.86 $9.98
EBITDA/Share $-0.27 $0.37 $-2.02 $-2.47 $-3.37 $-4.10 $-3.70 $-4.07 $-4.60 $-4.82 $-5.31 $-5.18 $-5.08 $-4.28 $-3.05 $-2.49 $-2.07 $-0.16 $2.13 $1.86 $1.86
Debt/Share $0.01 $0.01 $0.76 $0.76 $0.74 $0.74 $0.68 $0.70 $0.73 $0.73 $0.67 $0.66 $0.65 $0.62 $12.13 $12.06 $12.82 $12.73 $0.45 $0.49 $0.49
Net Debt/Share $-14.36 $-14.34 $-19.15 $-19.02 $-18.69 $-18.63 $-14.83 $-15.09 $-15.84 $-15.89 $-14.03 $-13.92 $-13.64 $-12.91 $-0.52 $-0.52 $-0.55 $-0.55 $-9.49 $-10.37 $-10.37
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.075
Altman Z-Prime snapshot only 4.744
Piotroski F-Score 5 6 4 3 3 3 2 1 3 4 3 4 3 3 5 5 5 4 5 6 6
Beneish M-Score -13.93 -5.74 -9.84 -7.85 7.13 -2.01 -0.68 -0.74 -0.64 3.20 0.29 13.63 -117.54 4.52 1.96 0.04 -3.14 -4.51 -4.514
Ohlson O-Score snapshot only -5.064
ROIC (Greenblatt) snapshot only 15.64%
Net-Net WC snapshot only $0.80
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB
Credit Score 81.85 94.59 55.23 41.14 37.44 42.19 39.05 38.85 38.57 33.35 31.83 32.00 31.70 31.86 22.59 22.54 22.32 27.25 57.40 56.94 56.944
Credit Grade snapshot only 9
Credit Trend snapshot only 34.408
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 52
Sector Credit Rank snapshot only 49

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms